Sabic said it has signed a letter of intent with Japan's Mitsubishi Rayon to set up a joint venture with an estimated cost of $1 billion. The plant would produce 250,000 tons per year of methyl methacrylate monomers and is expected to start production in 2013, Sabic said in a statement.
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.
Part 3: Seven Theses for successful Digitalization in Pharma
The ECA Foundation, one of the most important not-for-profit organizations for regulatory expertise in the pharmaceutical industry, aims to become the largest independent GMP/GDP organization in the world.
How AI and Robotics are reshaping the race for materials discovery.
Part 1: Building a Business Case for Pharma 4.0
